Teva Found To Infringe Vifor Fresenius Kidney Drug Patent
A Delaware federal judge ruled Thursday that a patent on a Vifor Fresenius drug used to control phosphate levels in the blood of kidney disease patients is infringed by Teva Pharmaceuticals'...To view the full article, register now.
Already a subscriber? Click here to view full article